Our Impact – UKI2S

Antiverse

Engineering Biology

Antiverse is a techbio company designing antibodies for challenging drug targets like G-protein-coupled receptors (GPCRs) and ion channels. Embedded in cell membranes, GPCRs are difficult to purify– an essential step required to design antibodies against them.

Cobalt Light Systems

Partner Innovation

Across Europe and Asia’s busiest and most prestigious airports, Cobalt Light Systems’ technology is installed into security checkpoint operations to rapidly screen liquids for explosives and other potential threat materials.

Cryogenx

Defence & Security

As global temperatures rise - 700 million people are projected to be exposed to extreme heat by 2030 - so too does the danger of heatstroke - a deadly and fast-acting condition that can strike military personnel, frontline workers, and emergency responders alike. With traditional cooling methods falling short, new solutions are urgently needed.

HonuWorx

Defence & Security

As global efforts to tackle climate change ramp up, startup HonuWorx has its sights set on subsea. With its advanced tech, the company hopes to deliver something no other organisation has successfully achieved.

iFAST Diagnostics

Partner Innovation

Every year, antimicrobial resistance (AMR) claims the lives of over a million people globally. The delay in effective diagnosis is a major contributing factor, as traditional Antimicrobial Susceptibility Testing (AST) methods take 48-72 hours to yield results.

Luffy AI

Fusion

Imagine a future where industry, the backbone of society, is revitalised. The rising costs of labour and energy and a retiring workforce are significant cross-sector industrial challenges.

Messium

Partner Innovation

Nitrogen fertiliser is essential for modern agriculture, but it is also one of the most environmentally challenging inputs. Over 50% of fields across Europe and Australia are fertilised incorrectly, leading to wasted costs, unnecessary emissions, and reduced yields. Addressing this inefficiency is critical for food security, climate goals, and farmers’ profitability.

Oxford Space Systems

Space

How do you become the global leader in deployable antennas for space? Create a range of low cost, high performance, unfurlable antennas offering global coverage and redundancy.

Presymptom Health

Knowledge Assets

As the UK healthcare system struggles to keep pace with the Antimicrobial Resistance (AMR) crisis (identified by the World Health Organisation as one of the top 10 global public health threats).

Revolver

Engineering Biology

Revolver Therapeutics is at the forefront of a revolution in cancer treatment. By targeting transcription factors with innovative peptide-based therapeutics, the company is opening a new frontier in addressing previously untreatable cancers. With UKI2S backing and a clear focus on delivering impactful solutions, Revolver is poised to make a lasting difference in the fight against childhood gliomas and beyond.

Sention Technologies

Partner Innovation

From electric vehicles to renewable energy storage, batteries are the unsung heroes of the energy transition. But with high production scrap rates, costly recalls, and opaque performance metrics, the battery industry is crying out for smarter solutions. That’s where Sention Technologies comes in.

Silicon Microgravity

Defence & Security

Military teams on battlefields across the globe rely on Global Navigation Satellite Systems (GNSS) like GPS to execute their missions. There’s a rise in GNSS-denied environments though, which means that electronic warfare has become one of the most significant threats to military operations today.

SugaROx

Partner Innovation

It’s predicted that 208.3 million people will experience high levels of acute food insecurity in 2024. And with the global population projected to reach 9.8 billion by 2050, that figure is only going to increase.

SugaROx

Partner Innovation

With the global population projected to reach 9.8 billion by 2050, and over 208 million people already facing high levels of acute food insecurity in 2024, the need for sustainable food production has never been greater. Biostimulants have emerged as one of the most promising solutions to support global food security, with demand for these products growing at an estimated 11% CAGR.

Synthace

Engineering Biology

Biology will change the world. With it, we can feed, heal, and fuel people for generations to come. But enroute to these novel products, the research and development is complex, risky and costly.

Tokamak Energy

Fusion

The world faces multiple challenges in the energy sector over the next half century, and one of the most difficult questions is how to provide sufficient “baseload” power. The sector badly needs to wean itself off hydrocarbons but renewables such as wind and solar are not the whole answer.

twig

Engineering Biology

From food ingredients to personal care products, many of the products and services we rely on day to day are powered by fossil fuels and intensive farming. Unfortunately this is no longer sustainable — if we’re to meet the challenges of global warming and achieve net zero.

World leading experts Fusion Energy Partners secure funding to accelerate fusion energy commercialisation

Fusion

Fusion consultancy bridges the gap between research and commercial applications with 250+ years of combined expertise. £100,000 UKI2S investment supports the transition of fusion energy from research to real-world technology Led by experts from UKAEA’s Joint European Torus (JET) programme, providing strategic guidance for the private sector Funding supports consultancy growth, commercial partnerships, and the UK's leadership in sustainable fusion energy

Case studies

Antiverse

Cobalt Light Systems

Cryogenx

HonuWorx

iFAST Diagnostics

Luffy AI

Messium

Oxford Space Systems

Presymptom Health

Revolver

Sention Technologies

Silicon Microgravity

SugaROx

SugaROx

Synthace

Tokamak Energy

twig

World leading experts Fusion Energy Partners secure funding to accelerate fusion energy commercialisation

Are you looking to commercialise your innovation?

Our financial statements

Stay updated